TrialInvestigational new drugs2020

A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma.

Paul L Swiecicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.